Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Thibault

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Xenotransplantation|February 18, 2003
Analysis of human CD4 T lymphocyte proliferation induced by porcine lymphoblastoid B cell linesChristine Bonenfant, Isabelle Vallée, Jishan Sun, et al.
International Journal of Molecular Sciences|July 2, 2021
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated PatientsGilles Thibault, Gilles Paintaud, Hsueh Cheng Sung, et al.
Journal of Leukocyte Biology|September 3, 2016
Neutrophils can disarm NK cell response through cleavage of NKp46Alexandre Valayer, Deborah Brea, Laurie Lajoie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activationLaurie Lajoie, Nicolas Congy-Jolivet, Armelle Bolzec, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patientsBertrand Lioger, Soujanya Ratna Edupuganti, Denis Mulleman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 16, 2015
CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimenGilles Thibault, Gilles Paintaud, Christophe Legendre, et al.
Mabs|July 30, 2014
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouseMarie Vincent, Géraldine Teppaz, Laurie Lajoie, et al.
Pharmaceutical Research|November 22, 2007
Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulizationAgnès Maillet, Nicolas Congy-Jolivet, Sandrine Le Guellec, et al.
Transplant Immunology|March 20, 2013
Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trialMatthias Büchler, Hélène Longuet, Roxane Lemoine, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2018
CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cellsPhilippe Gatault, Sally Al-Hajj, Johan Noble, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Xenotransplantation|February 18, 2003
Analysis of human CD4 T lymphocyte proliferation induced by porcine lymphoblastoid B cell linesChristine Bonenfant, Isabelle Vallée, Jishan Sun, et al.
International Journal of Molecular Sciences|July 2, 2021
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated PatientsGilles Thibault, Gilles Paintaud, Hsueh Cheng Sung, et al.
Journal of Leukocyte Biology|September 3, 2016
Neutrophils can disarm NK cell response through cleavage of NKp46Alexandre Valayer, Deborah Brea, Laurie Lajoie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activationLaurie Lajoie, Nicolas Congy-Jolivet, Armelle Bolzec, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patientsBertrand Lioger, Soujanya Ratna Edupuganti, Denis Mulleman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 16, 2015
CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimenGilles Thibault, Gilles Paintaud, Christophe Legendre, et al.
Mabs|July 30, 2014
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouseMarie Vincent, Géraldine Teppaz, Laurie Lajoie, et al.
Pharmaceutical Research|November 22, 2007
Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulizationAgnès Maillet, Nicolas Congy-Jolivet, Sandrine Le Guellec, et al.
Transplant Immunology|March 20, 2013
Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trialMatthias Büchler, Hélène Longuet, Roxane Lemoine, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2018
CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cellsPhilippe Gatault, Sally Al-Hajj, Johan Noble, et al.
Pageof 4